Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3‐kinase–protein kinase B pathway in diabetic rats

por Ni, Wei‐Jian, Zhou, Hong, Ding, Hai‐Hua, Tang, Li‐Qin
Publicado 2019

MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy

por Zhou, Hong, Ni, Wei-Jian, Meng, Xiao-Ming, Tang, Li-Qin
Publicado 2021

Corrigendum: MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy

por Zhou, Hong, Ni, Wei-Jian, Meng, Xiao-Ming, Tang, Li-Qin
Publicado 2022

Renoprotective effect of berberine via regulating the PGE (2)‐EP1‐Gαq‐Ca(2+) signalling pathway in glomerular mesangial cells of diabetic rats

por Ni, Wei‐Jian, Tang, Li‐Qin, Zhou, Hong, Ding, Hai‐Hua, Qiu, Yuan‐Ye
Publicado 2016

Berberine regulates mesangial cell proliferation and cell cycle to attenuate diabetic nephropathy through the PI3K/Akt/AS160/GLUT1 signalling pathway

por Ni, Wei‐Jian, Guan, Xi‐Mei, Zeng, Jing, Zhou, Hong, Meng, Xiao‐Ming, Tang, Li‐Qin
Publicado 2022

Co-delivery of a tumor microenvironment-responsive disulfiram prodrug and CuO(2) nanoparticles for efficient cancer treatment

por Cheng, Fen-Ting, Geng, Ya-Di, Liu, Yun-Xiao, Nie, Xuan, Zhang, Xin-Ge, Chen, Zhao-Lin, Tang, Li-Qin, Wang, Long-Hai, You, Ye-Zi, Zhang, Lei
Publicado 2023